Zobrazeno 1 - 10
of 31
pro vyhledávání: '"N Simon, Tchekmedyian"'
Autor:
Mary Hickman, Jessie Siau, Joseph Aisner, Henry Browder, F. Anthony Greco, N. Simon Tchekmedyian, James H. Keller
Publikováno v:
Cancer. 69:1268-1274
High-dose megestrol acetate has been associated with increased appetite and weight. To examine the effects of high-dose megestrol acetate in the treatment of anorexia and weight loss in patients with advanced hormone-insensitive malignant lesions, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8000d118412a3da42e9eaa3171759862
https://doi.org/10.1002/cncr.2820690532
https://doi.org/10.1002/cncr.2820690532
Autor:
N Simon, Tchekmedyian
Publikováno v:
Oncology (Williston Park, N.Y.). 29(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0eec9d73fa39575ba409d82afaeca958
https://pubmed.ncbi.nlm.nih.gov/26281837
https://pubmed.ncbi.nlm.nih.gov/26281837
Publikováno v:
Clinical Drug Investigation. 26:593-601
Objective: This study set out to identify the resource use and time commitment associated with treatment of anaemia with erythropoietic therapy, for both haematology/oncology clinics and patients. Methods: The study was carried out at three haematolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19985804c36fb922dd75ba7699c2bd66
https://doi.org/10.2165/00044011-200626100-00006
https://doi.org/10.2165/00044011-200626100-00006
Publikováno v:
Clinical Lung Cancer. 6:170-174
The results of a retrospective exploratory analysis of a phase III trial of zoledronic acid in patients with bone metastases secondary to lung cancer or other solid tumors are reported herein to assess the risk of skeletal-related events (SREs) and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0abe1be1931f72158050e5969a1fe8c0
https://doi.org/10.3816/clc.2004.n.030
https://doi.org/10.3816/clc.2004.n.030
Autor:
Sharon Yee, Randi Isaacs, Eric P. Lester, Eric Chevlen, Michael Ames, Thomas M. Beck, Jim H. Harvey, Howard D. Homesley, Stefan Madajewicz, Mary R. Creed, N. Simon Tchekmedyian, David Sciortino, Karen H. Crawford, William Whaley, Jesse I. Spector
Publikováno v:
The Oncologist. 3:432-438
Purpose: To compare the efficacy and safety of oral ondansetron with i.v. granisetron each given as a single dose prior to administration of highly emetogenic cisplatin chemotherapy. Patients and Methods: Chemotherapy-naive patients with histological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7616876b600c6e28a1dc8f9195b5120b
https://doi.org/10.1634/theoncologist.3-6-432
https://doi.org/10.1634/theoncologist.3-6-432
Autor:
Michael B. Jameson, William R. Wilson, Yongchuan Gu, Ramesh K. Ramanathan, N. Simon Tchekmedyian, Mark J. McKeage, Joseph G. Rajendran, Teresa J. Melink
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 496 (2012)
BMC Cancer
BMC Cancer
Background The purpose of this phase Ib clinical trial was to determine the maximum tolerated dose (MTD) of PR-104 a bioreductive pre-prodrug given in combination with gemcitabine or docetaxel in patients with advanced solid tumours. Methods PR-104 w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64dc999b6d430d843992f775c25a8920
http://www.biomedcentral.com/1471-2407/12/496
http://www.biomedcentral.com/1471-2407/12/496
Publikováno v:
Cancer investigation. 28(8)
Baseline and disease progression characteristics may predict the risk of skeletal-related events (SREs) in patients with bone metastases from various solid tumors. Exploratory analysis of phase III trials compared zoledronic acid with placebo in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3efd7404dd24956710becf7d65502ddd
https://pubmed.ncbi.nlm.nih.gov/20590447
https://pubmed.ncbi.nlm.nih.gov/20590447
Publikováno v:
Journal of Parenteral and Enteral Nutrition. 16:88S-92S
The endpoints used as outcome variables in clinical cancer treatment trials, including nutrition intervention studies, should contain items that are meaningful to the patient. Variables to consider are appetite, food intake, physical performance, psy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd4aeec536b8f55d5b59a4b657a45897
https://doi.org/10.1177/014860719201600610
https://doi.org/10.1177/014860719201600610
Publikováno v:
Supportive cancer therapy. 1(1)
Anemia is becoming recognized as a substantial problem for patients with cancer who are not receiving chemotherapy. Recently, darbepoetin alfa has been shown to provide significant clinical benefits in this patient population. This analysis assesses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a88b7cec6207f8d8cb42df951d8f472e
https://pubmed.ncbi.nlm.nih.gov/18628131
https://pubmed.ncbi.nlm.nih.gov/18628131
Autor:
James P. Allison, Lawrence Fong, N. Simon Tchekmedyian, Israel Lowy, Eric J. Small, Brian I. Rini
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 13(6)
Purpose: Blockade of the T-cell inhibitory receptor CTL-associated antigen-4 (CTLA-4) augments and prolongs T-cell responses and is a strategy to elicit antitumor immunity. The objectives of this pilot study were to establish the pharmacokinetic and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf91cde7de40bb6fe8efff5ab730afdb
https://pubmed.ncbi.nlm.nih.gov/17363537
https://pubmed.ncbi.nlm.nih.gov/17363537